Overview

The global Collagen Peptide and Gelatin Market was valued at USD 3.37 billion in 2025 and is projected to reach USD 6.68 billion by 2034, growing at a CAGR of 7.91% during the forecast period (2026-2034). The market is driven by increasing consumer demand for joint health, skin elasticity, and sports recovery products, alongside expanding use of gelatin as a functional excipient across the food, pharmaceutical, and nutraceutical industries. The market is shifting from conventional generic, commodity-grade gelatin and collagen hydrolysate toward bioactive, clinically studied peptide compositions engineered for specific health outcomes such as joint comfort, bone density, gut integrity, and metabolic wellness. Government initiatives such as the Canadian Food Inspection Agency's January 2025 decision to eliminate the zoosanitary certificate requirement for bulk imports of bovine-derived gelatin and collagen, aligning with World Organisation for Animal Health (WOAH) guidance that no longer classifies these materials as a BSE risk, are easing cross-border trade of gelatin and collagen raw materials. By region, Europe held the largest share of the market in 2025, supported by the concentration of leading gelatin and collagen peptide manufacturers across Germany, France, Belgium, Italy, and the Netherlands. Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by rising nutraceutical consumption in China, Japan, and India and expanding regional collagen peptide manufacturing capacity.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Rise of Bioactive Collagen Peptides for Targeted Health Applications Emerging as a Transformational Trend

• Manufacturers are increasingly developing specific bioactive collagen peptide compositions engineered for targeted physiological outcomes such as joint comfort, bone density support, and skin elasticity, rather than offering generic collagen hydrolysates, reflecting a broader shift toward clinically substantiated, application-specific ingredient science within the nutraceutical and functional food industries.
• Producers are expanding marine and fish-sourced collagen peptide portfolios to serve halal, kosher, and pescatarian consumer segments, alongside sustainability-focused sourcing from fish processing by-products, as brands seek to diversify away from bovine and porcine raw material dependence while meeting religious dietary certification requirements across international markets.
• Collagen peptide formats are diversifying beyond traditional powders into ready-to-drink beverages, gummies, and multi-benefit blends combining collagen with adaptogens, vitamins, or hyaluronic acid, as ingredient suppliers respond to changing consumer preferences for convenient, palatable delivery formats that fit into daily wellness and beauty-from-within routines.
• Rousselot received European, Japanese, and Chinese patents in September 2025 for Colartix, a hydrolyzed cartilage matrix formulated to support joint discomfort relief, reinforcing how leading collagen peptide manufacturers are protecting proprietary bioactive compositions through international intellectual property filings as competitive differentiation intensifies.

 

KEY MARKET DRIVER

Aging Global Population and Rising Joint Health Awareness Driving Market Growth

• The World Health Organization projects that the global population aged 60 years and older will nearly double from current levels to reach approximately 2.1 billion by 2050, directly expanding the addressable consumer base for collagen peptide and gelatin-based joint health, bone density, and skin elasticity supplements worldwide.
• Rising global incidence of osteoarthritis and related joint disorders is increasing consumer and clinical interest in hydrolyzed collagen and gelatin-derived ingredients as non-pharmaceutical options for supporting cartilage structure and mobility, encouraging both dietary supplement brands and pharmaceutical formulators to incorporate collagen peptides into joint care product lines.
• Growing sports nutrition and active-lifestyle consumer segments are adopting collagen peptides for muscle recovery, tendon support, and connective tissue health, supported by clinical studies published by ingredient manufacturers demonstrating measurable improvements in recovery time and joint comfort among recreational and competitive athletes following regular supplementation.
• Canada's Food Inspection Agency eliminated the zoosanitary certificate requirement for bulk imports of bovine-derived gelatin and collagen in January 2025, following World Organisation for Animal Health guidance that no longer classifies these materials as a BSE risk, easing cross-border trade friction for gelatin and collagen raw materials

 

KEY MARKET OPPORTUNITY

Expansion into Functional Beverages and Biomedical Applications Creating Significant Market Opportunity

• Growing consumer interest in functional beverages is creating opportunities for collagen peptide suppliers to develop water-soluble, heat-stable ingredient grades suited for ready-to-drink formats, allowing beverage manufacturers to position collagen as a mainstream functional ingredient alongside protein and electrolyte offerings in sports drinks and everyday hydration products.
• Untapped demand in personalized nutrition is opening opportunities for collagen peptide manufacturers to develop targeted formulations addressing specific consumer needs such as metabolic wellness, cognitive support, and gut health, moving beyond generic beauty and joint positioning toward differentiated, science-backed product platforms with premium pricing potential.
• Expansion of biomedical and regenerative medicine applications, including gelatin methacryloyl for tissue engineering and cell-based research, presents a high-value growth avenue for gelatin manufacturers capable of meeting stringent pharmaceutical-grade purity, endotoxin control, and traceability requirements demanded by medical device and cell therapy developers.
• Darling Ingredients and Tessenderlo Group signed a definitive agreement to combine their Rousselot and PB Leiner collagen and gelatin businesses into a new joint venture, Nextida, projected to generate approximately USD 1.5 billion in annual revenue and operate facilities across four continents upon closing in 2026. 

Collagen Peptide and Gelatin Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Product Type

Gelatin held the largest market share in 2025, supported by its long-established use as a gelling and film-forming agent in hard and soft capsule shells, confectionery, and processed food products across both the pharmaceutical and food industries. Its functional versatility, well-documented safety profile, and compatibility with existing large-scale manufacturing infrastructure make gelatin the preferred choice for capsule manufacturers and food formulators seeking a cost-effective, natural gelling ingredient with decades of regulatory acceptance across major markets.

 

Collagen peptides are projected to grow at the fastest CAGR during the forecast period, driven by surging consumer demand for ingestible beauty, joint health, and sports recovery supplements that require the smaller, highly soluble peptide fragments rather than gel-forming gelatin. Growing clinical research validating specific bioactive collagen peptide compositions for skin elasticity and joint comfort is encouraging supplement brands and functional food manufacturers to reformulate products around differentiated, science-backed collagen peptide ingredients.

 

Product Type categories include

                ·           Gelatin (Dominating Segment)

                ·           Collagen Peptides (Fastest-growing Segment)

 

Analysis by Source

Bovine-sourced collagen held the largest market share in 2025, supported by the wide global availability of cattle hides and bones as raw material, established hydrolysis and extraction infrastructure across major producing regions, and broad regulatory acceptance of bovine gelatin and collagen peptides in food, pharmaceutical, and nutraceutical applications across North America, Europe, and Latin America. Bovine sources also offer favorable cost economics and consistent gel strength that meet the specifications required by capsule and confectionery manufacturers.

 

Fish-sourced collagen is projected to grow at the fastest CAGR during the forecast period, supported by rising demand from halal, kosher, and pescatarian consumer segments, along with growing scientific interest in the smaller peptide molecular weight and higher bioavailability associated with marine collagen. Manufacturers are increasingly sourcing fish skins and scales from seafood processing by-products, aligning marine collagen production with broader industry sustainability and circular-sourcing objectives while addressing religious and dietary sourcing restrictions on bovine and porcine materials.

 

Source Categories include

                ·           Bovine (Dominating Segment)

                ·           Fish (Fastest-growing Segment)

                ·           Porcine

                ·           Poultry

                ·           Others

 

Analysis by Form

Powder held the largest market share in 2025 because of its long shelf stability, ease of transport, and compatibility with a wide range of end applications spanning dietary supplements, functional foods, and industrial gelatin uses. Powder-format collagen peptides and gelatin allow manufacturers to precisely control dosing and formulation ratios, and the format is readily incorporated into capsules, sachets, and bulk food manufacturing processes without requiring specialized handling equipment, reinforcing its position as the standard commercial form across most application categories.

 

Liquid collagen peptide and gelatin formats are projected to grow at the fastest CAGR during the forecast period supported by expanding use in ready-to-drink functional beverages, liquid supplement shots, and pre-dosed daily wellness products that appeal to consumers seeking convenient, on-the-go consumption without mixing or dissolving powder. Beverage manufacturers are increasingly formulating collagen directly into shelf-stable liquid concentrates, supporting faster market entry for brands targeting the growing functional beverage and liquid nutraceutical categories.

 

Form Categories include

                ·           Powder (Dominating Segment)

                ·           Liquid (Fastest-growing Segment)

                ·           Granules

                ·           Sheets

 

Analysis by Application

Food held the largest market share in 2025, accounting for a substantial portion of global gelatin and collagen peptide demand due to widespread use of gelatin in confectionery, dairy, and processed meat products, where its unique gelling, stabilizing, and texturizing properties are difficult to replace with plant-based alternatives. The long-standing regulatory approval of gelatin as a food additive across major jurisdictions, combined with decades of established use in large-scale food manufacturing, continues to anchor its position as the single largest application category for gelatin and collagen peptide ingredients.

 

Dietary supplements are projected to grow at the fastest CAGR during the forecast period, driven by rising global consumer awareness of collagen's role in skin elasticity, joint mobility, and healthy aging, alongside expanding retail and e-commerce distribution of collagen peptide powders, capsules, and gummies formulated specifically as daily supplements. Ingredient manufacturers are increasingly directing new product development and clinical research investment toward this segment to support evidence-based marketing claims that differentiate premium collagen peptide supplement brands from conventional food-grade gelatin.

 

Application categories include

           ·           Food (Dominating Segment)

           ·           Dietary Supplements (Fastest-growing Segment)

           ·           Beverage

           ·           Pharmaceuticals

           ·           Cosmetics

           ·           Photography 

By Region

Collagen Peptide and Gelatin Market Regional Analysis

Regional Analysis

Europe held the largest market share in 2025, supported by the concentration of long-established gelatin and collagen peptide manufacturers headquartered in Germany, France, Belgium, Italy, and the Netherlands, several of which operate integrated production networks spanning raw material collection through finished peptide manufacturing. Germany and France anchor the region through advanced collagen peptide research and export-oriented manufacturing, while Belgium and Italy maintain strong positions in gelatin production for pharmaceutical capsule and food applications. The region benefits from established regulatory frameworks under the EU Animal By-Products Regulation governing the sourcing and processing of animal-derived raw materials used in collagen and gelatin production.

 

Asia-Pacific is projected to grow at the fastest CAGR during the forecast period, driven by rising nutraceutical and functional food consumption in China, Japan, and India, alongside expanding domestic collagen peptide and gelatin manufacturing capacity to serve both regional and export markets. Japan maintains an established base of collagen peptide expertise through long-operating regional manufacturers, while China is experiencing rapid growth in domestic gelatin and collagen peptide production capacity to meet rising demand for dietary supplements and functional food ingredients. India is emerging as a growing hub for nutraceutical formulation and collagen-based dietary supplement consumption.

 

Countries and Regions Covered

Europe (Dominating Region)

o    Germany (Largest Country Market)

o    France

o    Belgium

o    Italy

o    Rest of Europe

Asia-Pacific (Fastest Growing Region)

o    China (Largest Country Market)

o    Japan

o    India (Fastest-Growing Country Market)

o    Rest of Asia-Pacific

North America

o    United States (Largest Country Market)

o    Canada

o    Mexico

Latin America

o    Brazil (Largest Country Market)

o    Rest of Latin America

Middle East & Africa

o    Saudi Arabia (Largest Country Market)

o    Rest of Middle East & Africa

Market Share

The Collagen Peptide and Gelatin Market is consolidated with a small number of long-established European and Japanese manufacturers accounting for a large share of global gelatin and collagen peptide production, alongside a growing base of regional Chinese, Brazilian, and Indian producers expanding capacity. Key success factors include integrated raw material sourcing, pharmaceutical-grade purity and traceability, and clinically substantiated bioactive peptide portfolios. Leading companies are prioritizing consolidation through mergers and joint ventures, expansion of marine and fish-sourced collagen capacity, and continued investment in bioactive peptide research to differentiate branded ingredients from commodity-grade gelatin and collagen hydrolysate.

 

Key Players

                            ·           GELITA AG (Germany)

                            ·           Nitta Gelatin, Inc. (Japan)

                            ·           Weishardt International SAS (France)

                            ·           Lapi Gelatine S.p.A. (Italy)

                            ·           Ewald-Gelatine GmbH (Germany)

                            ·           Trobas Gelatine B.V. (Netherlands)

                            ·           Italgel S.r.l. (Italy)

                            ·           Baotou Dongbao Bio-Tech Co., Ltd. (China)

                            ·           Hainan Huayan Collagen Technology Co., Ltd. (China)

                            ·           Jellice Co., Ltd. (Japan)

                            ·           Geltech Co., Ltd. (South Korea)

                            ·           India Gelatine & Chemicals Ltd. (India)

                            ·           Gelnex Indústria e Comércio Ltda. (Brazil)

                            ·           Nippi Inc. (Japan)

                            ·           Junca Gelatines S.L. (Spain)

 

Recent Market Developments

• In December 2025, Darling Ingredients and Tessenderlo Group signed a definitive agreement finalizing the formation of Nextida, a joint venture expected to combine gelatin and collagen production across facilities in South America, North America, Europe, and Asia, with the transaction expected to close in 2026 pending regulatory approval.
• In September 2025, Rousselot received European, Japanese, and Chinese patents for Colartix, a hydrolyzed cartilage matrix formulated to support joint discomfort relief, strengthening its bioactive collagen peptide intellectual property portfolio in the joint health segment.
• In April 2025, The Canadian Food Inspection Agency eliminated the requirement for a zoosanitary certificate for bulk imports of bovine-derived gelatin and collagen, aligning with World Organisation for Animal Health guidelines that no longer classify these materials as a BSE risk.
• In October 2025, GELITA launched EASYSEAL, a pharmaceutical-grade gelatin engineered for reliable softgel seam integrity, and PeptENDURE, a new collagen peptide targeting endurance athletes, at SupplySide West in Las Vegas, expanding its portfolio into both pharmaceutical-grade excipients and sports nutrition applications. 

Frequently Asked Questions